AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
AMLODIPINE in Zimbabwe
6 products registered with MCAZ — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AMILODIPINE 10 MG TABLET; ORAL | 2019/12.6/5884 | N2SA LIMITED | active | 30 Mar 2031 |
| AMLO-DA 10 TABLET; ORAL | 2024/12.6/6753 | DATLABS PRIVATE LIMITED | active | 5 Nov 2029 |
| AMLO-DA 5 TABLET; ORAL | 2024/12.6/6752 | DATLABS PRIVATE LIMITED | active | 5 Nov 2029 |
| AMLODIPAC 5 TABLET; ORAL | 2020/12.6/6032 | PLUS FIVE PHARMACEUTICALS PVT LTD | active | 31 Dec 2027 |
| AMLODIPAC 2.5 TABLET; ORAL | 2020/12.6/6031 | PLUS FIVE PHARMACEUTICALS PVT LTD | active | 31 Dec 2027 |
| AMLODIPAC 10 TABLET; ORAL | 2020/12.6/6033 | PLUS FIVE PHARMACEUTICALS PVT LTD | active | 31 Dec 2027 |
AMLODIPINE — MCAZ Registration Details
MCAZ (Zimbabwe) has 6 registered products containing AMLODIPINE, of which 6 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track AMLODIPINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.